ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 75 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $344,000 | +1.5% | 109,231 | -16.2% | 0.00% | – |
| Q4 2016 | $339,000 | -29.7% | 130,335 | +5.2% | 0.00% | – |
| Q3 2016 | $482,000 | +44.7% | 123,926 | 0.0% | 0.00% | – |
| Q2 2016 | $333,000 | +21.5% | 123,926 | +91.7% | 0.00% | – |
| Q2 2015 | $274,000 | -17.7% | 64,632 | -25.0% | 0.00% | – |
| Q1 2015 | $333,000 | -42.6% | 86,154 | 0.0% | 0.00% | – |
| Q4 2014 | $580,000 | +10.3% | 86,154 | -10.0% | 0.00% | – |
| Q3 2014 | $526,000 | -45.1% | 95,724 | +2.4% | 0.00% | -100.0% |
| Q2 2014 | $958,000 | -7.7% | 93,505 | +8.2% | 0.00% | 0.0% |
| Q1 2014 | $1,038,000 | -22.1% | 86,404 | -26.7% | 0.00% | 0.0% |
| Q4 2013 | $1,333,000 | +5.0% | 117,837 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $1,269,000 | +23.2% | 117,837 | +6.0% | 0.00% | 0.0% |
| Q2 2013 | $1,030,000 | – | 111,117 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |